Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ADMET and DMPK is Scopus-indexed (Q1, CiteScore 7.5), WoS ESCI, DOAJ. Published by International Association of Physical Chemists.
Checked against the index lists dated .
ISSN 1848-7718Verify ISSN ↗
Publisher: International Association of Physical Chemists
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 7 / 79 | 91st | Q1 |
| Medicine (miscellaneous) | 65 / 466 | 86th | Q1 |
| Pharmacology (medical) | 49 / 278 | 82nd | Q1 |
| Chemistry (miscellaneous) | 42 / 137 | 69th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 7.5.
ADMET and DMPK is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 7 of 79), Q1 in Medicine (miscellaneous) (rank 65 of 466) and Q1 in Pharmacology (medical) (rank 49 of 278), by CiteScore 2025. It is ranked in 4 subject areas in all.
ADMET and DMPK is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.5, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.825, quartile Q1, with an H-index of 29.
ADMET and DMPK is published by International Association of Physical Chemists. Its ISSN is 1848-7718.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
ADMET and DMPK has an h-index of 31 and a 2-year mean of 4.95 citations per paper (OpenAlex). Its Scopus CiteScore is 7.5, quartile Q1. On 2-year citations it ranks #5 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
ADMET and DMPK published 61 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from India (18.8%), Iraq (12.4%) and Indonesia (10.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.